Business Segments · Cost of Sales
Business Segments — Cost of Sales
Amgen Business Segments — Cost of Sales decreased by 13.1% to $2.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.8%, from $2.53B to $2.18B. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2024
Last reportedQ1 2026
Rolls up toTotal Cost of Revenue
How to read this metric
An increase relative to revenue suggests margin compression, while a decrease indicates improved manufacturing efficiency or economies of scale.
Detailed definition
Includes the direct costs associated with the manufacturing, production, and distribution of the company's therapeutic p...
Peer comparison
Commonly reported as 'Cost of Goods Sold' (COGS) across the industry.
Metric ID:
amgn_segment_reportable_segment_cost_of_salesHistorical Data
7 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $2.81B | $2.83B | $2.85B | $2.53B | $2.48B | $2.51B | $2.18B |
| QoQ Change | — | +0.4% | +1.0% | -11.4% | -1.7% | +1.0% | -13.1% |
| YoY Change | — | — | — | -10.2% | -12.1% | -12.1% | -13.8% |
Range$2.18B – $2.85B
CAGR-15.6%
Avg YoY Growth-12.0%
Median YoY Growth-12.1%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's business segments — cost of sales?
- Amgen (AMGN) reported business segments — cost of sales of $2.18B in Q1 2026.
- How has Amgen's business segments — cost of sales changed year-over-year?
- Amgen's business segments — cost of sales decreased by 13.8% year-over-year, from $2.53B to $2.18B.
- What does business segments — cost of sales mean?
- The direct costs incurred to produce and deliver the company's products to customers.